Ieq Capital LLC grew its stake in shares of Molina Healthcare, Inc (NYSE:MOH - Free Report) by 104.2% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 43,886 shares of the company's stock after buying an additional 22,397 shares during the period. Ieq Capital LLC owned 0.08% of Molina Healthcare worth $14,456,000 at the end of the most recent reporting period.
Other hedge funds also recently bought and sold shares of the company. Price T Rowe Associates Inc. MD boosted its holdings in shares of Molina Healthcare by 46.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 3,838,043 shares of the company's stock worth $1,264,214,000 after purchasing an additional 1,216,903 shares during the last quarter. T. Rowe Price Investment Management Inc. boosted its holdings in shares of Molina Healthcare by 8.6% during the first quarter. T. Rowe Price Investment Management Inc. now owns 1,487,896 shares of the company's stock worth $490,099,000 after purchasing an additional 117,796 shares during the last quarter. GAMMA Investing LLC boosted its holdings in shares of Molina Healthcare by 74,593.7% during the first quarter. GAMMA Investing LLC now owns 667,015 shares of the company's stock worth $219,708,000 after purchasing an additional 666,122 shares during the last quarter. Northern Trust Corp boosted its holdings in shares of Molina Healthcare by 14.9% during the fourth quarter. Northern Trust Corp now owns 607,601 shares of the company's stock worth $176,842,000 after purchasing an additional 78,950 shares during the last quarter. Finally, Jacobs Levy Equity Management Inc. boosted its holdings in shares of Molina Healthcare by 6.4% during the fourth quarter. Jacobs Levy Equity Management Inc. now owns 537,057 shares of the company's stock worth $156,310,000 after purchasing an additional 32,273 shares during the last quarter. Hedge funds and other institutional investors own 98.50% of the company's stock.
Molina Healthcare Price Performance
MOH traded up $6.15 during trading on Monday, reaching $180.87. The stock had a trading volume of 1,489,455 shares, compared to its average volume of 1,498,875. The firm has a market capitalization of $9.80 billion, a price-to-earnings ratio of 8.91 and a beta of 0.54. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.77. Molina Healthcare, Inc has a 1-year low of $151.95 and a 1-year high of $365.23. The stock has a 50 day moving average of $199.34 and a two-hundred day moving average of $273.25.
Molina Healthcare (NYSE:MOH - Get Free Report) last released its earnings results on Wednesday, July 23rd. The company reported $5.48 earnings per share for the quarter, missing analysts' consensus estimates of $5.50 by ($0.02). The firm had revenue of $11.43 billion during the quarter, compared to analyst estimates of $10.94 billion. Molina Healthcare had a return on equity of 27.72% and a net margin of 2.60%.The business's revenue for the quarter was up 15.7% on a year-over-year basis. During the same quarter last year, the company earned $5.86 earnings per share. As a group, equities analysts anticipate that Molina Healthcare, Inc will post 24.4 EPS for the current fiscal year.
Insiders Place Their Bets
In other news, COO James Woys bought 10,000 shares of the business's stock in a transaction on Monday, August 4th. The shares were bought at an average cost of $155.94 per share, with a total value of $1,559,400.00. Following the purchase, the chief operating officer directly owned 74,331 shares in the company, valued at $11,591,176.14. This trade represents a 15.54% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Ronna Romney sold 700 shares of the business's stock in a transaction on Wednesday, August 6th. The shares were sold at an average price of $153.74, for a total transaction of $107,618.00. Following the sale, the director directly owned 17,131 shares in the company, valued at approximately $2,633,719.94. This trade represents a 3.93% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.26% of the stock is currently owned by corporate insiders.
Wall Street Analyst Weigh In
A number of research firms have issued reports on MOH. Cantor Fitzgerald reissued a "neutral" rating and set a $210.00 price target on shares of Molina Healthcare in a research report on Tuesday, August 26th. UBS Group lowered their price objective on Molina Healthcare from $260.00 to $180.00 and set a "neutral" rating for the company in a report on Friday, July 25th. Barclays decreased their price objective on Molina Healthcare from $270.00 to $186.00 and set an "equal weight" rating for the company in a report on Friday, July 25th. Wall Street Zen lowered Molina Healthcare from a "buy" rating to a "hold" rating in a report on Sunday, June 29th. Finally, Wells Fargo & Company decreased their price objective on Molina Healthcare from $216.00 to $198.00 and set an "overweight" rating for the company in a report on Friday, August 15th. Three equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $242.91.
View Our Latest Stock Report on Molina Healthcare
Molina Healthcare Company Profile
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Read More

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here

We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report